International Journal of Head and Neck Surgery

Register      Login

VOLUME 13 , ISSUE 4 ( October-December, 2022 ) > List of Articles


A Rare Case of Rhino-orbital Mucormycosis with Intracranial Tuberculosis in Latent Post Coronavirus Disease 2019 Diabetic Patient

Uma Nataraj, Merlin Babu, Frenali Godhani

Keywords : Coronavirus disease 2019, Diabetes, Fungal infection, Mucormycosis, Rhino-orbital, Tuberculosis

Citation Information : Nataraj U, Babu M, Godhani F. A Rare Case of Rhino-orbital Mucormycosis with Intracranial Tuberculosis in Latent Post Coronavirus Disease 2019 Diabetic Patient. Int J Head Neck Surg 2022; 13 (4):104-108.

DOI: 10.5005/jp-journals-10001-1541

License: CC BY-NC 4.0

Published Online: 21-01-2023

Copyright Statement:  Copyright © 2022; The Author(s).


Aim: To report a rare case of rhino-orbital mucormycosis with intracranial tuberculosis in a latent post-coronavirus disease 2019 (COVID-19) diabetic patient. Background: Mucormycosis has been found to have a predilection for COVID-19 patients, while diabetes mellitus and other immunocompromised conditions act as independent risk factors for both. In this case, there is an additional immunocompromised risk factor of tuberculosis. Case description: We report the case of a 61-year-old male patient, a long-standing diabetic with positive COVID antibodies, in an unvaccinated patient diagnosed with rhino-orbital mucormycosis with suspected intracranial extension. Magnetic resonance imaging (MRI) of the brain, paranasal sinuses (PNS), and orbit revealed sinusitis, predominantly involving both maxillary, ethmoid, and right medial frontal sinuses, with intracranial extension in the right basifrontal brain parenchyma, and involvement of right medial extraconal orbit abutting muscles. Potassium hydroxide (KOH) mount of nasal swab and nasal biopsy showed broad branching aseptate hyphae consistent with mucormycosis. Functional endoscopic sinus surgery (FESS) and neurosurgical intervention, together with microbiological evidence, supported the diagnosis of rhino-orbital mucormycosis with intracranial tuberculosis. Due to underlying uncontrolled diabetes and tuberculosis, it was difficult to manage medically. Amphotericin, the mainstay of treatment for mucormycosis being nephrotoxic, and as the patient has diabetic nephropathy, was an additional challenge to manage as he developed severe renal dysfunction. He was successfully managed with surgical intervention involving FESS, medial wall orbitotomy, frontal craniotomy with debridement, and antituberculosis treatment. Conclusion: Diagnosis, reversal of risk factors, surgical debridement of infected tissue, and appropriate therapy forms the mainstay of the management of mucormycosis. The contributory risk factors should be managed adequately to decrease and control morbidity. Clinical significance: Early and proper diagnosis of mucormycosis in an unvaccinated patient with positive covid antibodies, diabetes mellitus, and intracranial tuberculosis is essential and will further require aggressive management and surgical intervention at the earliest stage possible so as to prevent mortality.

PDF Share
  1. Kim JG, Park HJ, Park JH, et al. Importance of immediate surgical intervention and antifungal treatment for rhinocerebral mucormycosis: a case report. J Korean Assoc Oral Maxillofac Surg 2013;39(5):246–250. DOI: 10.5125/jkaoms.2013.39.5.246
  2. Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005;41(5):634–653. DOI: 10.1086/432579
  3. Petrikkos G, Skiada A, Lortholary O, et al. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis 2012;54(Suppl 1):S23–S34. DOI: 10.1093/cid/cir866
  4. Patel A, Kaur H, Xess I, et al. A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India. Clin Microbiol Infect 2020;26(7):944.e9–944.e15. DOI: 10.1016/j.cmi.2019.11.021
  5. Afroze S, Korlepara R, Rao G, et al. Mucormycosis in a diabetic patient: a case report with an insight into its pathophysiology. Contemp Clin Dent 2017;8(4):662–666. DOI: 10.4103/ccd.ccd_558_17
  6. Katragkou A, Walsh TJ, Roilides E. Why is mucormycosis more difficult to cure than more common mycoses? Clin Microbiol Infect 2014;20(Suppl 6):74–81. DOI: 10.1111/1469-0691.12466
  7. Banerjee M, Pal R, Bhadada SK. Intercepting the deadly trinity of mucormycosis, diabetes and COVID-19 in India. Postgrad Med J 2021;postgradmedj-2021–140537. DOI: 10.1136/postgradmedj-2021-140537
  8. Singh AK, Singh R, Joshi SR, et al. Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India. Diabetes Metab Syndr 2021;15(4):102146. DOI: 10.1016/j.dsx.2021.05.019
  9. Honavar SG. Code mucor: guidelines for the diagnosis, staging and management of rhino-orbito-cerebral mucormycosis in the setting of COVID-19. Indian J Ophthalmol 2021;69(6):1361–1365. DOI: 10.4103/ijo.IJO_1165_21m
  10. Mehta S, Pandey A. Rhino-orbital mucormycosis associated with COVID-19. Cureus 2020;12(9):e10726. DOI: 10.7759/cureus.10726
  11. Cornely O, Chakrabarti A. PS1284 Global guideline for the diagnosis and management of mucormycosis: an initiative of the ECMM in cooperation with the MSG ERC. HemaSphere 2019;3(S1):588. DOI: 10.1097/01.HS9.0000563416.43453.d2
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.